,title,source,link,date
0,Glenmark secures FDA approval for fluphenazine hydrochloride tablets,BusinessLine,news.google.com/articles/CBMihQFodHRwczovL3d3dy50aGVoaW5kdWJ1c2luZXNzbGluZS5jb20vbWFya2V0cy9nbGVubWFyay1zZWN1cmVzLWZkYS1hcHByb3ZhbC1mb3ItZmx1cGhlbmF6aW5lLWh5ZHJvY2hsb3JpZGUtdGFibGV0cy9hcnRpY2xlNjc1MDc5NDMuZWNl0gGKAWh0dHBzOi8vd3d3LnRoZWhpbmR1YnVzaW5lc3NsaW5lLmNvbS9tYXJrZXRzL2dsZW5tYXJrLXNlY3VyZXMtZmRhLWFwcHJvdmFsLWZvci1mbHVwaGVuYXppbmUtaHlkcm9jaGxvcmlkZS10YWJsZXRzL2FydGljbGU2NzUwNzk0My5lY2UvYW1wLw?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-07
26,Hypercalcemia Treatment Market worth $39.83 billion by 2030 ...,openPR,news.google.com/articles/CBMiXmh0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMjc4NTkwL2h5cGVyY2FsY2VtaWEtdHJlYXRtZW50LW1hcmtldC13b3J0aC0zOS04My1iaWxsaW9uLWJ5LTIwMzDSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-07
2,"Glenmark Pharma receives ANDA approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg",ThePrint,news.google.com/articles/CBMinAFodHRwczovL3RoZXByaW50LmluL2FuaS1wcmVzcy1yZWxlYXNlcy9nbGVubWFyay1waGFybWEtcmVjZWl2ZXMtYW5kYS1hcHByb3ZhbC1mb3ItZmx1cGhlbmF6aW5lLWh5ZHJvY2hsb3JpZGUtdGFibGV0cy11c3AtMS1tZy0yLTUtbWctNS1tZy1hbmQtMTAtbWcvMTgzNTY0OC_SAaABaHR0cHM6Ly90aGVwcmludC5pbi9hbmktcHJlc3MtcmVsZWFzZXMvZ2xlbm1hcmstcGhhcm1hLXJlY2VpdmVzLWFuZGEtYXBwcm92YWwtZm9yLWZsdXBoZW5hemluZS1oeWRyb2NobG9yaWRlLXRhYmxldHMtdXNwLTEtbWctMi01LW1nLTUtbWctYW5kLTEwLW1nLzE4MzU2NDgvP2FtcA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-07
3,Glenmark Shares Surge as USFDA Grants Approval for Generic Drug Used to Treat Certain Mental Disorders,EquityPandit,news.google.com/articles/CBMihAFodHRwczovL3d3dy5lcXVpdHlwYW5kaXQuY29tL2dsZW5tYXJrLXNoYXJlcy1zdXJnZS1hcy11c2ZkYS1ncmFudHMtYXBwcm92YWwtZm9yLWdlbmVyaWMtZHJ1Zy11c2VkLXRvLXRyZWF0LWNlcnRhaW4tbWVudGFsLWRpc29yZGVycy_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-07
4,Glenmark Pharmaceuticals Receives ANDA Approval For Fluphenazine Hydrochloride Tablets,Free Press Journal,news.google.com/articles/CBMif2h0dHBzOi8vd3d3LmZyZWVwcmVzc2pvdXJuYWwuaW4vYnVzaW5lc3MvZ2xlbm1hcmstcGhhcm1hY2V1dGljYWxzLXJlY2VpdmVzLWFuZGEtYXBwcm92YWwtZm9yLWZsdXBoZW5hemluZS1oeWRyb2NobG9yaWRlLXRhYmxldHPSAYMBaHR0cHM6Ly93d3cuZnJlZXByZXNzam91cm5hbC5pbi9hbXAvYnVzaW5lc3MvZ2xlbm1hcmstcGhhcm1hY2V1dGljYWxzLXJlY2VpdmVzLWFuZGEtYXBwcm92YWwtZm9yLWZsdXBoZW5hemluZS1oeWRyb2NobG9yaWRlLXRhYmxldHM?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-07
5,Glenmark Pharma receives ANDA approval for Fluphenazine ...,PR Newswire,news.google.com/articles/CBMipwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9pbi9uZXdzLXJlbGVhc2VzL2dsZW5tYXJrLXBoYXJtYS1yZWNlaXZlcy1hbmRhLWFwcHJvdmFsLWZvci1mbHVwaGVuYXppbmUtaHlkcm9jaGxvcmlkZS10YWJsZXRzLXVzcC0xLW1nLTItNS1tZy01LW1nLWFuZC0xMC1tZy0zMDE5Nzk2MjIuaHRtbNIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-07
6,Glenmark gets USFDA nod for generic drug used to treat mental disorder,CNBCTV18,news.google.com/articles/CBMidWh0dHBzOi8vd3d3LmNuYmN0djE4LmNvbS9idXNpbmVzcy9nbGVubWFyay1nZXRzLXVzZmRhLW5vZC1mb3ItZ2VuZXJpYy1kcnVnLXVzZWQtdG8tdHJlYXQtbWVudGFsLWRpc29yZGVyLTE4MjYxNTMxLmh0bdIBeWh0dHBzOi8vd3d3LmNuYmN0djE4LmNvbS9idXNpbmVzcy9nbGVubWFyay1nZXRzLXVzZmRhLW5vZC1mb3ItZ2VuZXJpYy1kcnVnLXVzZWQtdG8tdHJlYXQtbWVudGFsLWRpc29yZGVyLTE4MjYxNTMxLmh0bS9hbXA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-07
11,"Antisynthetase syndrome Market Size, Share, Demand, Future ...",PharmiWeb.com,news.google.com/articles/CBMikwFodHRwczovL3d3dy5waGFybWl3ZWIuY29tL3ByZXNzLXJlbGVhc2UvMjAyMy0xMS0wNy9hbnRpc3ludGhldGFzZS1zeW5kcm9tZS1tYXJrZXQtc2l6ZS1zaGFyZS1kZW1hbmQtZnV0dXJlLWdyb3d0aC1jaGFsbGVuZ2VzLWFuZC1jb21wZXRpdGl2ZS1hbmFseXPSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-07
12,Stock Market Highlights: Nifty looks confused after 3-day rally. Hereâ€™s what traders should do on Wednesday,Economic Times,news.google.com/articles/CBMilgFodHRwczovL2Vjb25vbWljdGltZXMuaW5kaWF0aW1lcy5jb20vbWFya2V0cy9zdG9ja3MvbGl2ZS1ibG9nL2JzZS1zZW5zZXgtdG9kYXktbGl2ZS1uaWZ0eS1zdG9jay1tYXJrZXQtdXBkYXRlcy0wNy1ub3ZlbWJlci0yMDIzL2xpdmVibG9nLzEwNTAyNDgwMi5jbXPSAZoBaHR0cHM6Ly9lY29ub21pY3RpbWVzLmluZGlhdGltZXMuY29tL21hcmtldHMvc3RvY2tzL2xpdmUtYmxvZy9ic2Utc2Vuc2V4LXRvZGF5LWxpdmUtbmlmdHktc3RvY2stbWFya2V0LXVwZGF0ZXMtMDctbm92ZW1iZXItMjAyMy9hbXBfbGl2ZWJsb2cvMTA1MDI0ODAyLmNtcw?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-07
72,Pigmentation Disorder Treatment Market : Asia-Pacific Region is ...,openPR,news.google.com/articles/CBMiXmh0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMjc4Njc2L3BpZ21lbnRhdGlvbi1kaXNvcmRlci10cmVhdG1lbnQtbWFya2V0LWFzaWEtcGFjaWZpYy1yZWdpb27SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-07
